サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413108

顧みられない熱帯病治療市場：製品タイプ別、疾患タイプ別、診断方法別 - 2024年～2030年の世界予測

Neglected Tropical Disease Treatment Market by Product (Drugs, Vaccines), Types of Diseases (Buruli Ulcer, Chagas Disease, Dengue), Diagnostic Method - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 186 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
顧みられない熱帯病治療市場：製品タイプ別、疾患タイプ別、診断方法別 - 2024年～2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

顧みられない熱帯病治療市場規模は2023年に61億3,000万米ドルと推計され、2024年には64億米ドルに達し、CAGR 6.25%で2030年には93億8,000万米ドルに達すると予測されます。

顧みられない熱帯病治療の世界市場

主な市場の統計
基準年[2023年］ 61億3,000万米ドル
予測年[2024年］ 64億米ドル
予測年 [2030年] 93億8,000万米ドル
CAGR（%） 6.25%
顧みられない熱帯病治療 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは顧みられない熱帯病治療市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、顧みられない熱帯病治療市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-顧みられない熱帯病治療市場の市場規模および予測は？

2-顧みられない熱帯病治療市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-顧みられない熱帯病治療市場における技術動向と規制の枠組みは？

4-顧みられない熱帯病治療市場における主要ベンダーの市場シェアは？

5-顧みられない熱帯病治療市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 顧みられない熱帯病の治療に対する意識の高まり
      • 熱帯および亜熱帯諸国における顧みられない熱帯病の負担の増加
      • 研究開発への巨額の財政投資
    • 抑制要因
      • 薬の副作用
    • 機会
      • 治療に対する政府の有利な取り組み
      • 研究開発への投資の増加と治療プログラムの新規立ち上げ
    • 課題
      • 診断と治療のための標準化ツールの欠如
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 顧みられない熱帯病治療市場：製品別

  • 薬物
  • ワクチン

第7章 顧みられない熱帯病治療市場：疾患タイプ別

  • ブルーリ潰瘍
  • シャーガス病
  • デング熱
  • ヒトアフリカトリパノソーマ症
  • リーシュマニア症
  • ハンセン病
  • 狂犬病
  • 土壌伝染性蠕虫症
  • トラコーマ
  • ヨーズ

第8章 顧みられない熱帯病治療市場：診断方法別

  • 従来
  • 分子/現代

第9章 南北アメリカの顧みられない熱帯病治療市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋の顧みられない熱帯病治療市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの顧みられない熱帯病治療市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Amneal Pharmaceuticals LLC
    • Bayer AG
    • Daiichi Sankyo Company, Limited
    • Eisai Co., Ltd.
    • F. Hoffmann-La Roche Ltd
    • Insud Pharma, S.L.
    • Novartis AG
    • Oblita Therapeutics
    • Omega Diagnostics Group PLC
    • Oscar Medicare Pvt Ltd.
    • Sanofi S.A
    • Teva Pharmaceutical Industries Ltd
    • Themis Bioscience GmbH
    • Valneva SE
    • ZeptoMetrix, LLC
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. NEGLECTED TROPICAL DISEASE TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NEGLECTED TROPICAL DISEASE TREATMENT MARKET DYNAMICS
  • FIGURE 7. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2023 VS 2030 (%)
  • FIGURE 10. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2030 (%)
  • FIGURE 12. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. NEGLECTED TROPICAL DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 9. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY BURULI ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY CHAGAS DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DENGUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY HUMAN AFRICAN TRYPANOSOMIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY LEISHMANIASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY LEPROSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY SOIL-TRANSMITTED HELMINTHIASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TRACHOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY YAWS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 20. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY MOLECULAR/MODERN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 149. NEGLECTED TROPICAL DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 150. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. NEGLECTED TROPICAL DISEASE TREATMENT MARKET LICENSE & PRICING
目次
Product Code: MRR-AD36CD897E93

[186 Pages Report] The Neglected Tropical Disease Treatment Market size was estimated at USD 6.13 billion in 2023 and expected to reach USD 6.40 billion in 2024, at a CAGR 6.25% to reach USD 9.38 billion by 2030.

Global Neglected Tropical Disease Treatment Market

KEY MARKET STATISTICS
Base Year [2023] USD 6.13 billion
Estimated Year [2024] USD 6.40 billion
Forecast Year [2030] USD 9.38 billion
CAGR (%) 6.25%
Neglected Tropical Disease Treatment Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Neglected Tropical Disease Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Neglected Tropical Disease Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Neglected Tropical Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include Amneal Pharmaceuticals LLC, Bayer AG, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., F. Hoffmann-La Roche Ltd, Insud Pharma, S.L., Novartis AG, Oblita Therapeutics, Omega Diagnostics Group PLC, Oscar Medicare Pvt Ltd., Sanofi S.A, Teva Pharmaceutical Industries Ltd, Themis Bioscience GmbH, Valneva SE, and ZeptoMetrix, LLC.

Market Segmentation & Coverage

This research report categorizes the Neglected Tropical Disease Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Drugs
    • Vaccines
  • Types of Diseases
    • Buruli Ulcer
    • Chagas Disease
    • Dengue
    • Human African trypanosomiasis
    • Leishmaniases
    • Leprosy
    • Rabies
    • Soil-transmitted Helminthiases
    • Trachoma
    • Yaws
  • Diagnostic Method
    • Conventional
    • Molecular/Modern
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Neglected Tropical Disease Treatment Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Neglected Tropical Disease Treatment Market?

3. What are the technology trends and regulatory frameworks in the Neglected Tropical Disease Treatment Market?

4. What is the market share of the leading vendors in the Neglected Tropical Disease Treatment Market?

5. Which modes and strategic moves are suitable for entering the Neglected Tropical Disease Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Neglected Tropical Disease Treatment Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness of neglected tropical diseases treatments
      • 5.1.1.2. Increasing burden of neglected tropical disease in tropical and subtropical countries
      • 5.1.1.3. Huge financial investment in research & development
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects of the drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable government initiatives for the treatment
      • 5.1.3.2. Increasing investments in R&D and new launches in the treatment programs
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardization tools for diagnosis and treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Neglected Tropical Disease Treatment Market, by Product

  • 6.1. Introduction
  • 6.2. Drugs
  • 6.3. Vaccines

7. Neglected Tropical Disease Treatment Market, by Types of Diseases

  • 7.1. Introduction
  • 7.2. Buruli Ulcer
  • 7.3. Chagas Disease
  • 7.4. Dengue
  • 7.5. Human African trypanosomiasis
  • 7.6. Leishmaniases
  • 7.7. Leprosy
  • 7.8. Rabies
  • 7.9. Soil-transmitted Helminthiases
  • 7.10. Trachoma
  • 7.11. Yaws

8. Neglected Tropical Disease Treatment Market, by Diagnostic Method

  • 8.1. Introduction
  • 8.2. Conventional
  • 8.3. Molecular/Modern

9. Americas Neglected Tropical Disease Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neglected Tropical Disease Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Neglected Tropical Disease Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Amneal Pharmaceuticals LLC
    • 13.1.2. Bayer AG
    • 13.1.3. Daiichi Sankyo Company, Limited
    • 13.1.4. Eisai Co., Ltd.
    • 13.1.5. F. Hoffmann-La Roche Ltd
    • 13.1.6. Insud Pharma, S.L.
    • 13.1.7. Novartis AG
    • 13.1.8. Oblita Therapeutics
    • 13.1.9. Omega Diagnostics Group PLC
    • 13.1.10. Oscar Medicare Pvt Ltd.
    • 13.1.11. Sanofi S.A
    • 13.1.12. Teva Pharmaceutical Industries Ltd
    • 13.1.13. Themis Bioscience GmbH
    • 13.1.14. Valneva SE
    • 13.1.15. ZeptoMetrix, LLC
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing